Navigation Links
Harbinger Research Initiates Coverage on HearAtLast

TORONTO, Oct. 26 /PRNewswire-FirstCall/ -- HearAtLast, Inc., (Pink Sheets: HRAL) announced today that Harbinger Research LLC has initiated research coverage on the company. HearAtLast, Inc. The research report provides an investment rating, price target, and earnings model, in addition to a summary of the Company as an investment opportunity, an overview of its businesses, its sales and marketing strategy, and a discussion of the company's industry. To read the report please visit:

(Due to URL length, please copy and paste into your browser.)


Harbinger Research was contracted by the company to author the research report for the purpose of increasing investor awareness and informing both institutional and individual investors of the investment potential of the Company.

About Harbinger Research

Harbinger Research is a New York based independent equity research company. They provide equity research coverage to smaller U.S. traded companies and the individuals and institutions who invest in them. For more information on Harbinger Research, please visit

About HearAtLast, Inc.

HearAtLast Holdings, Inc. is a Nevada corporation that owns and operates its wholly-owned subsidiary HearAtLast Inc., a chain of hearing stores specializing in the sale of digital hearing aids and testing services. The company develops, owns, and operates hearing aid clinics co-located within select Wal-Mart stores throughout Canada. HearAtLast facilities sell a selection of high quality brand name hearing aids and also offer complimentary screening tests, clinical hearing tests, instant custom MP3 headphones and custom hearing protection. The Company's mission is to consolidate the highly fragmented hearing services industry while providing unparalleled service to the estimated 30+ million hearing impaired individuals throughout North America. After a prescription is approved, the independent on-site audiologists and hearing aid practitioners at HearAtLast utilize a refined process to dispense a hearing aid in about an hour.

Forward-Looking Statements

Such forward-looking statements are subject to a number of risks, assumptions and uncertainties that could cause the Company's actual results to differ materially from those projected in such forward-looking statements. These risks, assumptions and uncertainties include: the ability to complete systems within currently estimated time frames and budgets; the ability to compete effectively in a rapidly evolving and price competitive marketplace; changes in the nature of telecommunications regulation in the United States and other countries; changes in business strategy; the successful integration of newly acquired businesses; the impact of technological change; and other risks referenced from time to time in the Company's filings with the Securities and Exchange Commission.

Investor Relations:

Stephen Taylor

Taylor Capital, Inc.

Phone: 973-351-3868


SOURCE HearAtLast, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Attention Breakdown Is The Harbinger Of Alzheimers Disease
2. Severe Cold is Harbinger of Infections
3. Harbinger of Hope for Kala Azar Victims of Bihar
4. Kidney Stones - Interesting New Research implicates bacteria as its cause
5. Stem cell research- now Nobel Laureates join the debate
6. Researchers urge caution in using ear tube surgery
7. Paracetamol May Cause Live Damage Warns Consumer Education and Research Centre
8. Spouses and other partners lower blood pressure says new research
9. Researchers Scale to assess the Severity of Epilepsy in Kids
10. More Research Required For COPD
11. Researchers identify the early makers of Neonatal Sepsis
Post Your Comments:
(Date:10/12/2017)... ... October 12, 2017 , ... The company ... of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every ... meet the highest standard. , These products are also: Gluten Free, Non-GMO, ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) will ... during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual ... F. Collen, a pioneer in the field of medical informatics, this prestigious award is ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information ... we intend to develop to enable prevention of a major side effect of ... loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label ...
(Date:10/12/2017)... ... , ... HMP , a leader in healthcare events and education, today announced ... Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie ... competition recognizes editorial and design excellence across a range of sectors. This year’s program ...
(Date:10/12/2017)... FL (PRWEB) , ... October 12, 2017 , ... On ... holding a treadmill relay – Miles by Moonlight to raise money for the American ... $300 or more. , Teams will work together to keep their treadmills moving ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... HORSHAM, Pa. , Sept. 22, 2017 ... received a complete response letter from the U.S. Food ... (BLA) seeking approval of sirukumab for the treatment of ... response letter indicates additional clinical data are needed to ... of moderately to severely active RA. ...
(Date:9/22/2017)... SAN DIEGO , Sept. 22, 2017 ... ll medical device is now successfully helping those with ... Union. Fibromyalgia diagnosed Amanda in ... getting dressed and washing my hair, experiencing no sleep ... body in painful spasm… I cannot recommend [the AVACEN ...
(Date:9/19/2017)... --  ZirMed Inc ., a recognized leader in cloud-based revenue ... been ranked #1 by its users for the seventh consecutive ... Survey. ZirMed was recognized as the top-ranked end-to-end revenue cycle ... over 200 beds and holds one of the longest #1 ... ...
Breaking Medicine Technology: